Policy Brief
⭐ 4.9
Clinical Trials for Fortune 500 Firms: Operational Excellence | Evidence from DACH Region
Abstract
This policy brief investigates “Clinical Trials for Fortune 500 Firms: Operational Excellence | Evidence from DACH Region” using a difference-in-differences analysis. Through a human-centered lens, the analysis integrates multi-source data to derive an actionable roadmap for researchers and practitioners.